Indicated for: contraception
Substance: norgestimate + ethinylestradiol (hormonal contraceptive + estrogen)
ATC: G03AA11 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Progestogens and estrogens, fixed combinations)
The combination of norgestimate and ethinylestradiol is used as an oral contraceptive. It works by inhibiting ovulation, altering cervical mucus, and thinning the endometrium.
The medication is taken orally, as directed by a doctor, usually once daily at the same time each day for 21 days, followed by a 7-day break. It is important for patients to follow the administration schedule to ensure contraceptive efficacy.
Patients should be aware of potential side effects, such as nausea, headaches, or breast tenderness. It is important to inform the doctor of any unusual symptoms.
Common side effects include nausea, headaches, and breast tenderness. In rare cases, severe reactions such as deep vein thrombosis or allergic reactions may occur. Patients should be informed of these risks before use.